Search
for

    GlossaryBRAVE-AA2

    clinical trial evaluating baricitinib for severe alopecia areata

    BRAVE-AA2 is a clinical trial designed to evaluate the efficacy and safety of a drug called baricitinib for treating alopecia areata, an autoimmune condition that causes hair loss. The trial specifically focuses on adults with severe alopecia areata and aims to determine how well the drug can help regrow hair and improve patients' quality of life.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

    Community Join

    5 / 138 results